Important: New Login Process
We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.
- If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
- If you log in with a username and password, you will be prompted to set a new password before accessing your account.
Go to the Login Page to get started.
We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.
- Company Profiles
- Target Profiles
- Product Profiles
Explore BCIQ profiles by entering a company name.
Epicure Therapeutics Inc.
Headquarters: Seattle, WA, United States of America
Website: https://epicuregtx.com/
Year Founded: 2024
Status: Private
BioCentury | Mar 26, 2025
Discovery & Translation
Science Spotlight: New insight into LAG3’s checkpoint function
BioCentury’s roundup of translational innovations also includes a blood-based T cell assay for T1D, a degrader using a new E3 ligase, and papers from newcos
BioCentury | Mar 21, 2025
Editor's Commentary
Solving CNS delivery will open big doors for epigenome editing: a Perspective
Epigenome editors could shine in neurology indications not served by other modalities — but only if companies invest in delivery
Items per page:
1 - 2 of 2